ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 187,65
0,69%
Dow Jones
39 387,76
0,85%
DAX
18 686,60
1,07%
Brent Oil
83,95
0,47%
Bitcoin
62 714,52
2,50%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSXV
  6. ICO Therapeutics Inc (ICO)

  7. ICO Therapeutics Inc (ICO) Actualités

ICO

ICO Therapeutics (ICO)

ICO Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:TSXV:ICO
DateHeureSourceTitreSymboleSociété
17/08/202123h30PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - ICOTSXV:ICOICO Therapeutics Inc
17/08/202123h24PR Newswire (Canada)IIROC Trading Resumption - ICOTSXV:ICOICO Therapeutics Inc
22/03/202113h05PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - ICOTSXV:ICOICO Therapeutics Inc
22/03/202113h03PR Newswire (Canada)IIROC Trading Halt - ICOTSXV:ICOICO Therapeutics Inc
25/05/201622h00PR Newswire (Canada)iCo Therapeutics Announces First Quarter 2016 Financial ResultsTSXV:ICOICO Therapeutics Inc
14/04/201622h00PR Newswire (Canada)iCo Therapeutics Announces Year End 2015 Financial ResultsTSXV:ICOICO Therapeutics Inc
17/02/201623h35PR Newswire (Canada)iCo Therapeutics Inc. Announces Grant of Stock Options and Recent CEO Share PurchasesTSXV:ICOICO Therapeutics Inc
18/01/201613h00PR Newswire (Canada)iCo Strategic ReorganizationTSXV:ICOICO Therapeutics Inc
24/12/201513h00PR Newswire (Canada)iCo Therapeutics Announces Changes to Board of DirectorsTSXV:ICOICO Therapeutics Inc
25/11/201501h21PR Newswire (Canada)/C O R R E C T I O N from Source -- iCo Therapeutics Inc./TSXV:ICOICO Therapeutics Inc
24/11/201523h00PR Newswire (Canada)iCo Therapeutics Announces Third Quarter 2015 Financial ResultsTSXV:ICOICO Therapeutics Inc
26/10/201513h00PR Newswire (Canada)iCo Therapeutics Announces Manufacturing Update for Oral Amp B ProgramTSXV:ICOICO Therapeutics Inc
26/08/201523h00PR Newswire (Canada)iCo Therapeutics Announces Second Quarter 2015 Financial ResultsTSXV:ICOICO Therapeutics Inc
26/06/201522h00PR Newswire (Canada)iCo Therapeutics Announces Voting & Election Results from Annual Meeting of ShareholdersTSXV:ICOICO Therapeutics Inc
28/05/201523h00PR Newswire (Canada)iCo Therapeutics Announces First Quarter 2015 Financial ResultsTSXV:ICOICO Therapeutics Inc
27/04/201523h00PR Newswire (Canada)iCo Therapeutics Announces Year End 2014 Financial ResultsTSXV:ICOICO Therapeutics Inc
17/04/201521h15PR Newswire (Canada)iCo Therapeutics Inc. Comments on Recent Market ActivityTSXV:ICOICO Therapeutics Inc
28/11/201423h00PR Newswire (Canada)iCo Therapeutics Announces Third Quarter 2014 Financial Results and Corporate UpdateTSXV:ICOICO Therapeutics Inc
04/11/201413h00PR Newswire (Canada)iCo Therapeutics Announces Oral Amphotericin Presentations at AAPSTSXV:ICOICO Therapeutics Inc
22/10/201413h00PR Newswire (Canada)iCo Therapeutics Announces Advancement of Oral Amphotericin B ProgramTSXV:ICOICO Therapeutics Inc
29/08/201413h00PR Newswire (Canada)iCo Therapeutics Announces Second Quarter 2014 Financial ResultsTSXV:ICOICO Therapeutics Inc
19/08/201413h00PR Newswire (Canada)iCo Therapeutics Announces Positive Oral Amphotericin B Study ResultsTSXV:ICOICO Therapeutics Inc
15/07/201419h29PR Newswire (Canada)iCo Therapeutics Inc. - No Material ChangeTSXV:ICOICO Therapeutics Inc
30/06/201413h00PR Newswire (Canada)iCo Therapeutics Announces Director Election Results From Its Annual Meeting of ShareholdersTSXV:ICOICO Therapeutics Inc
09/06/201414h00PR Newswire (Canada)iCo Therapeutics Announces Top-Line Primary Endpoint Data from iCo-007 Phase 2 iDEAL Study in Diabetic Macular EdemaTSXV:ICOICO Therapeutics Inc
29/05/201423h00PR Newswire (Canada)iCo Therapeutics Announces First Quarter 2014 Financial ResultsTSXV:ICOICO Therapeutics Inc
29/04/201413h00PR Newswire (Canada)iCo Therapeutics Announces Poster Presentation at ARVOTSXV:ICOICO Therapeutics Inc
24/04/201423h00PR Newswire (Canada)iCo Therapeutics Announces Year End 2013 Financial ResultsTSXV:ICOICO Therapeutics Inc
26/03/201413h45Marketwired CanadaTrue Drinks Announces Scot Cohen as New DirectorTSXV:ICOICO Therapeutics Inc
05/03/201413h00PR Newswire (Canada)iCo Therapeutics Announces Final Eight Month Patient Visit in Phase 2 iDEAL StudyTSXV:ICOICO Therapeutics Inc
 Showing the most relevant articles for your search:TSXV:ICO

Dernières Valeurs Consultées

NYSE
JPM
JP Morgan Chase
NYSE
KO
Coca Cola
EU
CS
Axa
EU
MC
Lvmh Moet Hennessy Louis...
EU
CAP
Capgemini
EU
LR
Legrand
NYSE
NKE
Nike
EU
ACA
Credit Agricole
SPI
SP500
S&P 500
EU
PX1
CAC 40
EU
ORA
Orange
NYSE
MCD
McDonalds
EU
DG
Vinci
EU
BN
Danone
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés